PRJNA1221999 - A phase 1b study of Neoantigen Vaccine in combination with nivolumab and locally administered ipilimumab in patients with melanoma - OmicsDI

Genomics

Dataset Information

A phase 1b study of Neoantigen Vaccine in combination with nivolumab and locally administered ipilimumab in patients with melanoma

ABSTRACT: A phase 1b study of Neoantigen Vaccine in combination with nivolumab and locally administered ipilimumab in patients with melanoma

PROVIDER: PRJNA1221999 | ENA |

REPOSITORIES: ENA